Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alvaro Morales & Zvi Cohen. (2016) Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin. Expert Opinion on Biological Therapy 16:2, pages 273-283.
Read now
Read now
Marina A Dobrovolskaia & Scott E McNeil. (2015) Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics. Expert Opinion on Drug Delivery 12:7, pages 1163-1175.
Read now
Read now
Articles from other publishers (34)
Eike-Christian Wamhoff, Grant A. Knappe, Aurora A. Burds, Rebecca R. Du, Barry W. Neun, Simone Difilippantonio, Chelsea Sanders, Elijah F. Edmondson, Jennifer L. Matta, Marina A. Dobrovolskaia & Mark Bathe. (2023) Evaluation of Nonmodified Wireframe DNA Origami for Acute Toxicity and Biodistribution in Mice. ACS Applied Bio Materials 6:5, pages 1960-1969.
Crossref
Crossref
Kathryn H. Morelli, Aaron A. Smargon & Gene W. Yeo. (2023) Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders. RNA 29:4, pages 489-497.
Crossref
Crossref
Yasmine Radwan, Kirill A. Afonin & M. Brittany Johnson. 2023. RNA Nanostructures. RNA Nanostructures
211
228
.
Marina A. Dobrovolskaia. (2022) Lessons learned from immunological characterization of nanomaterials at the Nanotechnology Characterization Laboratory. Frontiers in Immunology 13.
Crossref
Crossref
Pranav Shah, Manisha Lalan & Kalyani Barve. (2022) Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders. Frontiers in Pharmacology 13.
Crossref
Crossref
Bernhard Laggerbauer & Stefan Engelhardt. (2022) MicroRNAs as therapeutic targets in cardiovascular disease. Journal of Clinical Investigation 132:11.
Crossref
Crossref
Macarena Hernández-Jiménez, Samuel Martín-Vílchez, Dolores Ochoa, Gina Mejía-Abril, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Bernd Jilma, María A. Moro, Gerónimo Fernández, David Piñeiro, Marc Ribó, Víctor M. González, Ignacio Lizasoain & Francisco Abad-Santos. (2022) First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers. Molecular Therapy - Nucleic Acids 28, pages 124-135.
Crossref
Crossref
Morgan Chandler, Brittany Johnson, Emil Khisamutdinov, Marina A. Dobrovolskaia, Joanna Sztuba-Solinska, Aliasger K. Salem, Koen Breyne, Roger Chammas, Nils G. Walter, Lydia M. Contreras, Peixuan Guo & Kirill A. Afonin. (2021) The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field. ACS Nano 15:11, pages 16957-16973.
Crossref
Crossref
Enrico Mastrobattista. (2021) Formulation and delivery solutions for the next generation biotherapeutics. Journal of Controlled Release 336, pages 583-597.
Crossref
Crossref
M. Brittany Johnson, Morgan Chandler & Kirill A. Afonin. (2021) Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects. Advanced Drug Delivery Reviews 173, pages 427-438.
Crossref
Crossref
Erha Basit, Farwa Batool Shamsi, Maryam Zaheer Kiyani, Shmaim Ramzan, Awais Ahmad, Anish Khan & Abdullah M Asiri. 2021. Nanomedicine Manufacturing and Applications. Nanomedicine Manufacturing and Applications
109
123
.
Marina A. Dobrovolskaia & Mark Bathe. (2020)
Opportunities and challenges for the clinical translation of structured
DNA
assemblies as gene therapeutic delivery and vaccine vectors
. WIREs Nanomedicine and Nanobiotechnology 13:1.
Crossref
Crossref
Manuel Hawner & Christian Ducho. (2020) Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules. Molecules 25:24, pages 5963.
Crossref
Crossref
Morgan Brittany Johnson, Justin R Halman, Daniel K Miller, Joseph S Cooper, Emil F Khisamutdinov, Ian Marriott & Kirill A Afonin. (2020) The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification. Nucleic Acids Research 48:20, pages 11785-11798.
Crossref
Crossref
Morgan Chandler, Morgan Brittany Johnson, Martin Panigaj & Kirill A Afonin. (2020) Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs). Current Opinion in Biotechnology 63, pages 8-15.
Crossref
Crossref
Jennifer R. Ferrer, Andrew J. Sinegra, David Ivancic, Xin Yi Yeap, Longhui Qiu, Jiao-Jing Wang, Zheng Jenny Zhang, Jason A. Wertheim & Chad A. Mirkin. (2020) Structure-Dependent Biodistribution of Liposomal Spherical Nucleic Acids. ACS Nano 14:2, pages 1682-1693.
Crossref
Crossref
Alexander Batista-Duharte, Luis Sendra, Maria Herrero, Damiana Téllez-Martínez, Iracilda Carlos & Salvador Aliño. (2020) Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement. Biomolecules 10:2, pages 316.
Crossref
Crossref
Marina A. Dobrovolskaia. (2019) Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies. Molecules 24:24, pages 4620.
Crossref
Crossref
Chandler & Afonin. (2019) Smart-Responsive Nucleic Acid Nanoparticles (NANPs) with the Potential to Modulate Immune Behavior. Nanomaterials 9:4, pages 611.
Crossref
Crossref
Enping Hong & Marina A. Dobrovolskaia. (2019) Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics. Advanced Drug Delivery Reviews 141, pages 3-22.
Crossref
Crossref
H. Denny Liggitt. 2019. Nanotechnology Characterization Tools for Environment, Health, and Safety. Nanotechnology Characterization Tools for Environment, Health, and Safety
65
102
.
Rachid Benchaouir & Aurelie Goyenvalle. 2019. Muscle Gene Therapy. Muscle Gene Therapy
355
370
.
Lauren Rackley, Jaimie Marie Stewart, Jacqueline Salotti, Andrey Krokhotin, Ankit Shah, Justin R. Halman, Ridhima Juneja, Jaclyn Smollett, Lauren Lee, Kyle Roark, Mathias Viard, Mubin Tarannum, Juan Vivero‐Escoto, Peter F. Johnson, Marina A. Dobrovolskaia, Nikolay V. Dokholyan, Elisa Franco & Kirill A. Afonin. (2018) RNA Fibers as Optimized Nanoscaffolds for siRNA Coordination and Reduced Immunological Recognition. Advanced Functional Materials 28:48, pages 1805959.
Crossref
Crossref
Enping Hong, Justin R. Halman, Ankit B. Shah, Emil F. Khisamutdinov, Marina A. Dobrovolskaia & Kirill A. Afonin. (2018) Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles. Nano Letters 18:7, pages 4309-4321.
Crossref
Crossref
Ofosua Adi-Dako, Kwabena Ofori-Kwakye, Kennedy Kwami Edem Kukuia, Jerry Asiedu-Larbi, Alexander Kwadwo Nyarko, Doris Kumadoh & Grace Frimpong. (2018) Cocoa Pod Husk Pectin Intended as a Pharmaceutical Excipient Has No Adverse Effects on Haematological Parameters in Sprague Dawley Rats. Journal of Pharmaceutics 2018, pages 1-10.
Crossref
Crossref
Bhawna Sharma, Rachael M. Crist & Pavan P. Adiseshaiah. (2017) Nanotechnology as a Delivery Tool for Precision Cancer Therapies. The AAPS Journal 19:6, pages 1632-1642.
Crossref
Crossref
Sophia J. Häfner, Thomas G. Talvard & Anders H. Lund. (2017) Long noncoding RNAs in normal and pathological pluripotency. Seminars in Cell & Developmental Biology 65, pages 1-10.
Crossref
Crossref
Marine Imbert, Gabriella Dias-Florencio & Aurélie Goyenvalle. (2017) Viral Vector-Mediated Antisense Therapy for Genetic Diseases. Genes 8:2, pages 51.
Crossref
Crossref
Jean Cornier, Andrew Owen, Arno Kwade & Marcel Van de VoordeMarina A. Dobrovolskaia. 2017. Pharmaceutical Nanotechnology: Innovation and Production. Pharmaceutical Nanotechnology: Innovation and Production
425
442
.
Justin R. Halman, Emily Satterwhite, Brandon Roark, Morgan Chandler, Mathias Viard, Anna Ivanina, Eckart Bindewald, Wojciech K. Kasprzak, Martin Panigaj, My N. Bui, Jacob S. Lu, Johann Miller, Emil F. Khisamutdinov, Bruce A. Shapiro, Marina A. Dobrovolskaia & Kirill A. Afonin. (2017) Functionally-interdependent shape-switching nanoparticles with controllable properties. Nucleic Acids Research, pages gkx008.
Crossref
Crossref
O. V. Sergeeva, V. E. Koteliansky & T. S. Zatsepin. (2016) mRNA-based therapeutics–Advances and perspectives. Biochemistry (Moscow) 81:7, pages 709-722.
Crossref
Crossref
Marina A. Dobrovolskaia, Michael Shurin & Anna A. Shvedova. (2016) Current understanding of interactions between nanoparticles and the immune system. Toxicology and Applied Pharmacology 299, pages 78-89.
Crossref
Crossref
Marina A. Dobrovolskaia. (2016) Self-assembled DNA/RNA nanoparticles as a new generation of therapeutic nucleic acids: immunological compatibility and other translational considerations. DNA and RNA Nanotechnology 3:1.
Crossref
Crossref
Marina A. Dobrovolskaia. (2015) Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy. Journal of Controlled Release 220, pages 571-583.
Crossref
Crossref